Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Marco Egbring"'
Autor:
Annika M. Jödicke, Urs Zellweger, Ivan T. Tomka, Thomas Neuer, Ivanka Curkovic, Malgorzata Roos, Gerd A. Kullak-Ublick, Hayk Sargsyan, Marco Egbring
Publikováno v:
BMC Health Services Research, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Rising health care costs are a major public health issue. Thus, accurately predicting future costs and understanding which factors contribute to increases in health care expenditures are important. The objective of this project wa
Externí odkaz:
https://doaj.org/article/d263932598b94496a119606f8ee21cdc
Autor:
Anne B Taegtmeyer, Ivanka Curkovic, Natascia Corti, Christoph Rosen, Marco Egbring, Stefan Russmann, Andreas R Gantenbein, Michael Weller, Gerd A Kullak-Ublick
Publikováno v:
Swiss Medical Weekly, Vol 142, Iss 2728 (2012)
QUESTIONS UNDER STUDY/PRINCIPLES: Data regarding the prevalence and types of drug-related problems (DRPs) among neurology inpatients is sparse. The objective of this study was to characterise the types of DRPs seen among neurology inpatients and furt
Externí odkaz:
https://doaj.org/article/70ccbd4bc8fd492d8908822762640e4f
Autor:
Andreas Trojan, Basil Bättig, Meinrad Mannhart, Burkhardt Seifert, Mathis N Brauchbar, Marco Egbring
BACKGROUND Digital monitoring of treatment-related symptoms and self-reported patient outcomes is important for the quality of care among cancer patients. As mobile devices are ubiquitous nowadays, the collection of electronic patient-reported outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e82ddec82a9c7f1e8901581347a048b
https://doi.org/10.2196/preprints.26950
https://doi.org/10.2196/preprints.26950
Autor:
Gerd A. Kullak-Ublick, Andrea M. Burden, Malgorzata Roos, Marco Egbring, Thomas Neuer, Ivanka Curkovic, Ivan T. Tomka, Urs Zellweger, Annika M. Jödicke
Publikováno v:
European Journal of Clinical Pharmacology, 76 (7)
European Journal of Clinical Pharmacology
European Journal of Clinical Pharmacology
Purpose Heart failure is among the leading causes for hospitalization in Europe. In this study, we evaluate potential precipitating factors for hospitalization for heart failure and shock. Methods Using Swiss claims data (2014–2015), we evaluated t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba3d93e6e019c99fa9176cdc6bbb01c4
Autor:
Urs Zellweger, Ivan T. Tomka, Annika M. Jödicke, Marco Egbring, Malgorzata Roos, Thomas Neuer, Ivanka Curkovic, Gerd A. Kullak-Ublick
Publikováno v:
Annals of Pharmacotherapy. 52:983-991
Potential drug-drug interactions (pDDIs) are described in various case reports, but few studies have evaluated the impact of specific combinations on a population level.To analyze the type and frequency of multiple contraindicated (X-pDDIs) and major
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c19fdbba7efef7f2250eb04370ba082
https://doi.org/10.1177/1060028018775914
https://doi.org/10.1177/1060028018775914
Publikováno v:
HIP International. 25:215-220
Introduction The influence of co-morbidities on complication rates and length of hospitalisation after surgery is well recognised. Clinical instruments predicting this influence, are of increasing interest. We sought to determine whether a count of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3321f4717829a549d4d851d6118e09f4
https://doi.org/10.5301/hipint.5000227
https://doi.org/10.5301/hipint.5000227
Autor:
Elmira Far, Marco Egbring, Gerd A. Kullak-Ublick, Mathis Brauchbar, Michael Dietrich, Malgorzata Roos, Andreas Trojan
Publikováno v:
Journal of Medical Internet Research
Background: The well-being of breast cancer patients and reporting of adverse events require close monitoring. Mobile apps allow continuous recording of disease- and medication-related symptoms in patients undergoing chemotherapy. Objective: The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc78c6f4ab3aefb5a81627da0f96f699
https://pubmed.ncbi.nlm.nih.gov/27601354
https://pubmed.ncbi.nlm.nih.gov/27601354
Autor:
Martin Huber, Alessandro Ceschi, Gerd A. Kullak-Ublick, Stefan Russmann, Ivanka Curkovic, Marco Egbring, Daniela Fritz
Publikováno v:
European Journal of Clinical Pharmacology. 68:1209-1219
Purpose: Clinical decision support systems (CDSS) are promoted as powerful screening tools to improve pharmacotherapy. The aim of our study was to evaluate the potential contribution of CDSS to patient management in clinical practice. Methods: We pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f596ba383aae5aedaa6272746062f052
https://doi.org/10.1007/s00228-012-1241-6
https://doi.org/10.1007/s00228-012-1241-6
Publikováno v:
Digestive diseases (Basel, Switzerland). 31(3-4)
Background: Glucocorticosteroids and aminosalicylates, mainly mesalazine (5-ASA), are both standard therapeutics in the treatment of inflammatory bowel disease (IBD) patients. The glucocorticosteroids are highly effective in inducing remission in bot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17a4db11fefbf6c06f42812d41d795f3
https://pubmed.ncbi.nlm.nih.gov/24246990
https://pubmed.ncbi.nlm.nih.gov/24246990
Publikováno v:
Praxis. 102(20)
The most common risks related to platelet inhibitor therapy are bleeding, drug-drug interactions and therapeutic failure. The new substances prasugrel and ticagrelor are more potent platelet inhibitiors than clopidogrel. This reduces the incidence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f87b67e0649f7c394c602ff7c8db643
https://pubmed.ncbi.nlm.nih.gov/24088235
https://pubmed.ncbi.nlm.nih.gov/24088235